| Accession | Title | Organisms | BioProject accession | Organization | Release time |
|---|---|---|---|---|---|
| SAMC784994 | msday21control | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC784993 | msday14control | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC784992 | msday7control | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309199 | mlym_Day21_2 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309198 | mlym_Day21_1 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309197 | mlym_Day14_2 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309196 | mlym_Day14_1 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309195 | mlym_Day7_2 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309194 | mlym_Day7_1 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309193 | mlym_Day0_2 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC309192 | mlym_Day0_1 | Mus musculus | PRJCA004238 | Zhongshan Ophthalmic Center,Sun Yat-sen University | 2022-08-11 |
| SAMC335210 | Beagle_hippocampus | Canis lupus familiaris | PRJCA004294 | Kunming Institute of Zoology, Chinese Academy of Sciences | 2022-08-11 |
| SAMC829350 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829349 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829348 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829347 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829346 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829345 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829344 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| SAMC829343 | RNA seq of mice | Mus | PRJCA010834 | Third Military Medical University(Army Medical University) | 2022-08-11 |
| Accession | Title | Organisms | Release Time |
|---|---|---|---|
| SAMN30223204 | Sample from a human female participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223203 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223202 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223201 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223200 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223199 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223198 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223197 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223196 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |
| SAMN30223195 | Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" | Homo sapiens | 2022-08-10 |